Koike K, Horinouchi T, Takayanagi I
Department of Chemical Pharmacology, Toho University School of Pharmaceutical Sciences, Chiba, Japan.
Jpn J Pharmacol. 1995 May;68(1):41-6. doi: 10.1254/jjp.68.41.
Experiments were carried out to examine the components of the intracellular second messenger system that is involved in beta 3-adrenoceptor (atypical beta-adrenoceptors)-mediated relaxation in the guinea pig taenia caecum. Propranolol and butoxamine caused competitive antagonism of the relaxant response to isoprenaline. However, propranolol or butoxamine did not significantly affect the relaxant responses to CGP 12177 (4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-2H- benzimidazol-2-one), a beta 3-adrenoceptor agonist. The concentration-response curves of the isoprenaline-induced increase in adenosine 3',5'-cyclic monophosphate (cyclic AMP) levels were shifted to the right in a parallel manner by propranolol and butoxamine. However, propranolol or butoxamine did not significantly affect the concentration-response curve for the CGP 12177-induced increase in cyclic AMP levels. MDL 12330 (cis-N-(2-phenylcyclopentyl)-azacyclotridec-1-en-2-amine) inhibited the isoprenaline- or CGP 12177-induced increase in cyclic AMP levels. These results suggest that the production of cyclic AMP contributes to the beta 3-adrenoceptor (or atypical beta-adrenoceptor)-mediated relaxation of the guinea pig taenia caecum.
开展实验以研究细胞内第二信使系统的组成成分,该系统参与豚鼠盲肠带中β3 -肾上腺素能受体(非典型β -肾上腺素能受体)介导的舒张反应。普萘洛尔和布托沙明对异丙肾上腺素引起的舒张反应产生竞争性拮抗作用。然而,普萘洛尔或布托沙明对β3 -肾上腺素能受体激动剂CGP 12177(4 - [3 - [(1,1 -二甲基乙基)氨基]-2 -羟基丙氧基]-1,3 -二氢-2H -苯并咪唑-2 -酮)引起的舒张反应没有显著影响。普萘洛尔和布托沙明使异丙肾上腺素诱导的3',5'-环磷酸腺苷(环磷腺苷)水平升高的浓度-反应曲线平行右移。然而,普萘洛尔或布托沙明对CGP 12177诱导的环磷腺苷水平升高的浓度-反应曲线没有显著影响。MDL 12330(顺式-N - (2 -苯基环戊基)-氮杂环十三碳-1 -烯-2 -胺)抑制异丙肾上腺素或CGP 12177诱导的环磷腺苷水平升高。这些结果表明,环磷腺苷的产生有助于豚鼠盲肠带中β3 -肾上腺素能受体(或非典型β -肾上腺素能受体)介导的舒张反应。